You are here: Industry Insights > HIV

News List

Scientists Use Gene-Editing Tool CRISPR in Attempt to Cure HIV drugs
September 16, 2019
The first attempt to use the gene-editing tool CRISPR to cure HIV infection was unsuccessful but the approach does show promise.
Having HIV May Heighten Stroke Risk drugs
September 10, 2019
People with HIV have a greatly increased risk of a common heart rhythm disorder that's a leading cause of stroke, a new study shows.
1984 to 2016 Saw Increase in Age of Death for HIV-Infected drugs
August 30, 2019
The mean age at death increased for patients with HIV infection from 1984 to 2016, according to a study published online in the Archives of Pathology & Laboratory Medicine.
Prurigo Nodularis Associated With Mental Health Disorders drugs
August 26, 2019
Prurigo nodularis (PN) is associated with mental health disorders, systemic illnesses, and HIV infection, according to a study published online in the Journal of Investigative Dermatology.
Poor HIV Control Ups Risk for Sudden Cardiac Death in Heart Failure drugs
August 26, 2019
Persons living with HIV (PHIV) who are hospitalized with heart failure are at an increased risk for subsequent sudden cardiac death (SCD)...
For Kids Born With HIV, Taking Needed Meds Gets Harder With Age: Study drugs
August 15, 2019
As they get older, U.S. children born with HIV are less likely to take the medicine they need to fight the AIDS-causing virus, a new study finds.
Worse Cancer Outcomes for Elderly HIV-Infected Patients drugs
August 12, 2019
Elderly HIV-infected patients with cancer have worse outcomes than HIV-uninfected patients with cancer, according to a study published online in JAMA Oncology.
Compliance With Meds Falters With Age in Youth Born With HIV drugs
August 05, 2019
For adolescents with perinatally acquired HIV, the prevalence of medication nonadherence and unsuppressed viral load increases with age...
Transmission Risks Up for HIV-Positive Injection Drug Users drugs
August 02, 2019
HIV-positive individuals who inject drugs are more likely to have a detectable viral load and engage in high-risk sexual behaviors...
ViiV and Janssen seek European approval for HIV two-drug regimen pharmaceutical-technology
July 31, 2019
ViiV Healthcare and Janssen Pharmaceutical have filed separate marketing authorisation applications (MAA) for the use of their respective drugs, cabotegravir and rilpivirine, as a combination therapy in adults with HIV infection.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page